| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C432747 |
1,1-dimethylbutyl-1-deoxy-Delta(9)-THC |
1,1-dimethylbutyl-1-deoxy-Delta(9)-THC binds to and results in increased activity of CNR2 protein | affects binding|increases activity | 15821753
|
| C432747 |
1,1-dimethylbutyl-1-deoxy-Delta(9)-THC |
[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC binds to and results in increased activity of CNR2 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] | affects binding|increases activity|increases reaction|increases secretion | 15821753
|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CNR2 mRNA | affects expression | 21346803
|
| C094503 |
2-arachidonylglycerol |
CNR2 protein affects the reaction [2-arachidonylglycerol results in increased expression of IL8 protein] | affects reaction|increases expression | 15115777
|
| C094503 |
2-arachidonylglycerol |
CNR2 protein affects the reaction [2-arachidonylglycerol results in increased transport of Calcium] | affects reaction|increases transport | 10617657
|
| C094503 |
2-arachidonylglycerol |
Pertussis Toxin inhibits the reaction [CNR2 protein affects the reaction [2-arachidonylglycerol results in increased transport of Calcium]] | affects reaction|decreases reaction|increases transport | 10617657
|
| C094503 |
2-arachidonylglycerol |
[SR 144528 binds to and results in increased activity of CNR2 protein] inhibits the reaction [2-arachidonylglycerol results in increased expression of IL8 protein] | affects binding|decreases reaction|increases activity|increases expression | 15115777
|
| C094503 |
2-arachidonylglycerol |
SR 144528 inhibits the reaction [CNR2 protein affects the reaction [2-arachidonylglycerol results in increased transport of Calcium]] | affects reaction|decreases reaction|increases transport | 10617657
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein | affects binding|increases activity | 10821843
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] which results in increased expression of ALDOC mRNA | affects binding|increases activity|increases expression | 10821843
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] which results in increased expression of BTG2 mRNA | affects binding|increases activity|increases expression | 10821843
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] which results in increased expression of CCL2 mRNA | affects binding|increases activity|increases expression | 10821843
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] which results in increased expression of CCL4 mRNA | affects binding|increases activity|increases expression | 10821843
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] which results in increased expression of IL8 mRNA | affects binding|increases activity|increases expression | 10821843
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] which results in increased expression of JUNB mRNA | affects binding|increases activity|increases expression | 10821843
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] which results in increased expression of NFKBIA mRNA | affects binding|increases activity|increases expression | 10821843
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] which results in increased expression of TNF mRNA | affects binding|increases activity|increases expression | 10821843
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to CNR2 protein | affects binding | 17397826 10688601
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 10218491
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein] | increases expression|increases reaction | 10218491
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of IL8 mRNA] | increases expression|increases reaction | 10218491
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of IL8 protein] | increases expression|increases reaction | 10218491
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
Ibuprofen analog inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to CNR2 protein] | affects binding|decreases reaction | 17397826
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
Pertussis Toxin inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
SR 144528 inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression|increases reaction | 10218491
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein]] | decreases reaction|increases expression|increases reaction | 10218491
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of IL8 mRNA]] | decreases reaction|increases expression|increases reaction | 10218491
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of IL8 protein]] | decreases reaction|increases expression|increases reaction | 10218491
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to CNR2 protein | affects binding | 10688601
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to CNR2 protein | affects binding | 10688601
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
CNR2 protein affects the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased phosphorylation of and results in increased activity of AKT1 protein] | affects reaction|increases activity|increases phosphorylation | 12734338
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
CNR2 protein affects the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 12734338
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
CNR2 protein affects the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased phosphorylation of and results in increased activity of MAPK3 protein] | affects reaction|increases activity|increases phosphorylation | 12734338
|
| C054649 |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein | affects binding|increases activity | 17220914
|
| C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of CNR2 mRNA | increases expression | 18648102
|
| D000242 |
Cyclic AMP |
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D000242 |
Cyclic AMP |
Pertussis Toxin inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D000242 |
Cyclic AMP |
Pertussis Toxin inhibits the reaction [[virodhamine binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D000242 |
Cyclic AMP |
SR 144528 inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D000242 |
Cyclic AMP |
SR 144528 inhibits the reaction [[virodhamine binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D000242 |
Cyclic AMP |
[virodhamine binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CNR2 mRNA | affects expression | 16483693
|
| C078814 |
anandamide |
anandamide affects the activity of CNR2 protein | affects activity | 19147270
|
| C078814 |
anandamide |
anandamide binds to and results in increased activity of CNR2 protein | affects binding|increases activity | 10617657
|
| C078814 |
anandamide |
anandamide binds to CNR2 protein | affects binding | 10688601
|
| C078814 |
anandamide |
anandamide binds to CNR2 protein | affects binding | 10688601
|
| C078814 |
anandamide |
anandamide binds to CNR2 protein | affects binding | 10688601
|
| D016718 |
Arachidonic Acid |
CNR2 protein affects the reaction [Arachidonic Acid results in increased expression of IL8 protein] | affects reaction|increases expression | 15115777
|
| D002118 |
Calcium |
CNR2 protein affects the reaction [2-arachidonylglycerol results in increased transport of Calcium] | affects reaction|increases transport | 10617657
|
| D002118 |
Calcium |
Pertussis Toxin inhibits the reaction [CNR2 protein affects the reaction [2-arachidonylglycerol results in increased transport of Calcium]] | affects reaction|decreases reaction|increases transport | 10617657
|
| D002118 |
Calcium |
SR 144528 inhibits the reaction [CNR2 protein affects the reaction [2-arachidonylglycerol results in increased transport of Calcium]] | affects reaction|decreases reaction|increases transport | 10617657
|
| D002251 |
Carbon Tetrachloride |
CNR2 gene mutant form results in increased susceptibility to Carbon Tetrachloride | increases response to substance | 15765409
|
| D013759 |
Tetrahydrocannabinol |
CNR2 protein affects the susceptibility to Tetrahydrocannabinol | affects response to substance | 18247131
|
| D013759 |
Tetrahydrocannabinol |
SR 144528 inhibits the reaction [CNR2 protein affects the susceptibility to Tetrahydrocannabinol] | affects response to substance|decreases reaction | 18247131
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CNR2 mRNA | affects cotreatment|increases expression | 17942748
|
| D005576 |
Forskolin |
[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D005576 |
Forskolin |
Pertussis Toxin inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D005576 |
Forskolin |
Pertussis Toxin inhibits the reaction [[virodhamine binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D005576 |
Forskolin |
SR 144528 inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D005576 |
Forskolin |
SR 144528 inhibits the reaction [[virodhamine binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D005576 |
Forskolin |
[virodhamine binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D007052 |
Ibuprofen |
Ibuprofen analog inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to CNR2 protein] | affects binding|decreases reaction | 17397826
|
| C094023 |
iodopravadoline |
iodopravadoline binds to and results in decreased activity of CNR2 protein | affects binding|decreases activity | 17018694
|
| C094023 |
iodopravadoline |
iodopravadoline binds to and results in decreased activity of CNR2 protein | affects binding|decreases activity | 16775503
|
| C402944 |
JHW 015 |
JHW 015 binds to CNR2 protein | affects binding | 10688601
|
| C402944 |
JHW 015 |
JHW 015 binds to CNR2 protein | affects binding | 10688601
|
| C402944 |
JHW 015 |
JHW 015 binds to CNR2 protein | affects binding | 10688601
|
| D008070 |
Lipopolysaccharides |
[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC binds to and results in increased activity of CNR2 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] | affects binding|increases activity|increases reaction|increases secretion | 15821753
|
| D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of CNR2 mRNA | decreases expression | 11448490
|
| C005958 |
palmidrol |
palmidrol binds to CNR2 protein | affects binding | 10688601 10617657
|
| C005958 |
palmidrol |
palmidrol binds to CNR2 protein | affects binding | 10688601
|
| C005958 |
palmidrol |
palmidrol binds to CNR2 protein | affects binding | 10688601
|
| D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [CNR2 protein affects the reaction [2-arachidonylglycerol results in increased transport of Calcium]] | affects reaction|decreases reaction|increases transport | 10617657
|
| D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [[virodhamine binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| C025299 |
polyphenols |
polyphenols results in decreased expression of CNR2 mRNA | decreases expression | 16293270
|
| C110630 |
SR 144528 |
[SR 144528 binds to and results in increased activity of CNR2 protein] inhibits the reaction [2-arachidonylglycerol results in increased expression of IL8 protein] | affects binding|decreases reaction|increases activity|increases expression | 15115777
|
| C110630 |
SR 144528 |
SR 144528 binds to CNR2 protein | affects binding | 10688601
|
| C110630 |
SR 144528 |
SR 144528 inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| C110630 |
SR 144528 |
SR 144528 inhibits the reaction [CNR2 protein affects the reaction [2-arachidonylglycerol results in increased transport of Calcium]] | affects reaction|decreases reaction|increases transport | 10617657
|
| C110630 |
SR 144528 |
SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA]] | decreases reaction|increases expression|increases reaction | 10218491
|
| C110630 |
SR 144528 |
SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein]] | decreases reaction|increases expression|increases reaction | 10218491
|
| C110630 |
SR 144528 |
SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of IL8 mRNA]] | decreases reaction|increases expression|increases reaction | 10218491
|
| C110630 |
SR 144528 |
SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of IL8 protein]] | decreases reaction|increases expression|increases reaction | 10218491
|
| C110630 |
SR 144528 |
SR 144528 inhibits the reaction [[virodhamine binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| C110630 |
SR 144528 |
SR 144528 binds to CNR2 protein | affects binding | 10688601
|
| C110630 |
SR 144528 |
SR 144528 binds to and results in decreased activity of CNR2 protein | affects binding|decreases activity | 12509806
|
| C110630 |
SR 144528 |
SR 144528 binds to CNR2 protein | affects binding | 10688601
|
| C110630 |
SR 144528 |
SR 144528 inhibits the reaction [CNR2 protein affects the susceptibility to Tetrahydrocannabinol] | affects response to substance|decreases reaction | 18247131
|
| C110630 |
SR 144528 |
SR 144528 binds to and results in decreased activity of CNR2 protein | affects binding|decreases activity | 16775503 15821753 16100529 15748152 14741435
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CNR2 mRNA | affects cotreatment|increases expression | 17942748
|
| C456739 |
virodhamine |
Pertussis Toxin inhibits the reaction [[virodhamine binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| C456739 |
virodhamine |
SR 144528 inhibits the reaction [[virodhamine binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP]] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| C456739 |
virodhamine |
[virodhamine binds to and results in increased activity of CNR2 protein] inhibits the reaction [Forskolin results in increased abundance of Cyclic AMP] | affects binding|decreases reaction|increases abundance|increases activity | 17558435
|
| C070417 |
Win 55212-2 |
Win 55212-2 binds to CNR2 protein | affects binding | 10688601
|
| C070417 |
Win 55212-2 |
Win 55212-2 binds to CNR2 protein | affects binding | 10688601
|
| C070417 |
Win 55212-2 |
CNR2 protein affects the reaction [Win 55212-2 results in increased phosphorylation of and results in increased activity of AKT1 protein] | affects reaction|increases activity|increases phosphorylation | 12734338
|
| C070417 |
Win 55212-2 |
CNR2 protein affects the reaction [Win 55212-2 results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 12734338
|
| C070417 |
Win 55212-2 |
CNR2 protein affects the reaction [Win 55212-2 results in increased phosphorylation of and results in increased activity of MAPK3 protein] | affects reaction|increases activity|increases phosphorylation | 12734338
|
| C070417 |
Win 55212-2 |
Win 55212-2 binds to CNR2 protein | affects binding | 10688601
|
| C070417 |
Win 55212-2 |
Win 55212-2 binds to and results in increased activity of CNR2 protein | affects binding|increases activity | 17220914
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.66 | 14514962 15322242 11752688 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.37 | 18287403 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.75 | 17505938 |
| MESH:D058186 |
Acute Kidney Injury |
|
Ibuprofen |
4.28 | 6375363 |
| MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.85 | 18653653 11850527 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.48 | 14692618 |
| MESH:D000230 |
Adenocarcinoma |
|
Ibuprofen |
4.48 | 10697514 |
| MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.64 | 3712494 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
| MESH:D000544 |
Alzheimer Disease |
|
Ibuprofen |
3.13 | 18351690 |
| MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Tetrahydrocannabinol |
4.71 | 15204022 |
| MESH:D000707 |
Anaphylaxis |
|
Ibuprofen |
5.06 | 9532969 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.78 | 11748828 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.28 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.55 | 15885639 |
| MESH:D050197 |
Atherosclerosis |
therapeutic |
|
| 15815632 |
| MESH:D050197 |
Atherosclerosis |
|
Tetrahydrocannabinol |
4.36 | 15815632 |
| MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
3.04 | 18582451 |
| MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.83 | 11289319 1440618 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.87 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.60 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.64 | 15746008 |
| MESH:D002545 |
Brain Ischemia |
|
Ibuprofen |
4.69 | 15837124 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.75 | 20435547 |
| MESH:D002100 |
Cachexia |
|
Ibuprofen |
5.28 | 15141370 |
| MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.59 | 15673190 10355542 15721981 16011737 15700767 16124888 16227642 16050911 3786805 16192424 16097048 18705752 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.65 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.39 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
4.39 | 7296757 3581430 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
4.39 | 18788625 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.59 | 7296757 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.26 | 18670907 18850075 16120746 |
| MESH:D002375 |
Catalepsy |
|
Tetrahydrocannabinol |
5.53 | 10318961 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
2.63 | 7505956 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.00 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.39 | 9022650 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.39 | 17681005 16919318 11677210 16105132 15861022 17110522 17333356 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.03 | 8697196 12621046 15340226 16354765 15668235 |
| MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.64 | 16293270 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 20055451 15322242 10048152 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.83 | 18551238 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.62 | 11906362 8970840 8156756 11298694 12868966 14531868 2524372 18759878 |
| MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.31 | 3621924 2952479 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.62 | 17107852 |
| MESH:D003967 |
Diarrhea |
|
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
4.71 | 10611417 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
11.40 | 18551238 21346803 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
11.40 | 7440962 6679447 16192314 9022650 1440618 9653073 18289764 6482804 11289319 8291058 9328219 18692083 18648102 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
11.40 | 7120509 4309450 11566570 15027814 6623471 2869522 15998439 6884620 3786805 7179309 15968718 17522070 3732212 16227642 19085960 21278145 16177239 10092053 7440962 9327722 19336974 10915739 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
11.40 | 19370779 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.40 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.62 | 11462148 |
| MESH:D004374 |
Ductus Arteriosus, Patent |
|
Ibuprofen |
5.42 | 18446180 18450898 16133044 |
| MESH:D004487 |
Edema |
|
Arachidonic Acid |
6.55 | 11698051 9599246 9831321 7990266 16716910 15177302 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.55 | 12711302 11000095 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.71 | 15322242 16714409 18230668 |
| MESH:D004660 |
Encephalitis |
|
2-arachidonylglycerol |
6.75 | 16364651 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.01 | 12538720 |
| MESH:D004715 |
Endometriosis |
|
Ibuprofen |
8.68 | 15652904 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.68 | 10568697 9294722 |
| MESH:D019446 |
Endotoxemia |
|
Ibuprofen |
10.18 | 11545620 |
| MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
10.18 | 15328337 15821434 17637181 |
| MESH:D004827 |
Epilepsy |
|
Tetrahydrocannabinol |
4.39 | 821787 |
| MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.06 | 3581430 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
7.12 | 16239168 61145 15959796 12795759 17595544 12631006 19224547 16045604 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.12 | 15345470 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.27 | 11858732 |
| MESH:D005334 |
Fever |
|
Arachidonic Acid |
14.50 | 11852909 |
| MESH:D005334 |
Fever |
|
Ibuprofen |
14.50 | 16997862 |
| MESH:D005334 |
Fever |
|
Lipopolysaccharides |
14.50 | 11852909 9205823 |
| MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.83 | 6705139 |
| MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
7.97 | 18705752 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.97 | 20067830 |
| MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.86 | 7505956 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.40 | 10696789 |
| MESH:D016489 |
Head Injuries, Closed |
|
2-arachidonylglycerol |
6.75 | 16364651 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.23 | 11294989 10048152 |
| MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.22 | 16366002 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.16 | 11000095 |
| MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
8.61 | 6705139 |
| MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.61 | 19110552 19900420 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.71 | 15340226 12621046 16120746 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 16959395 8697196 18606429 16354765 |
| MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.34 | 16899240 |
| MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.75 | 15034207 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.84 | 18670907 18850075 |
| MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.90 | 15338365 |
| MESH:D006984 |
Hypertrophy |
|
Ibuprofen |
4.80 | 16672835 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.62 | 16945680 16569931 |
| MESH:D007022 |
Hypotension |
|
anandamide |
5.57 | 14504685 |
| MESH:D007035 |
Hypothermia |
|
Tetrahydrocannabinol |
5.73 | 10318961 |
| MESH:D007235 |
Infant, Premature, Diseases |
|
Ibuprofen |
5.64 | 16133044 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.28 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.36 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
14.86 | 15177302 17371808 9831321 |
| MESH:D007249 |
Inflammation |
|
Ibuprofen |
14.86 | 3291741 |
| MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
14.86 | 12878042 17237260 9205823 17255318 17963957 |
| MESH:D007249 |
Inflammation |
|
polyphenols |
14.86 | 16366677 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
14.86 | 12200463 12878042 |
| MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.45 | 17255318 |
| MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.83 | 9022650 8074119 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 16580747 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
6.84 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.84 | 6582329 |
| MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.85 | 16316344 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
marker/mechanism |
|
| 15039279 |
| MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.51 | 15821434 |
| MESH:D008103 |
Liver Cirrhosis |
marker/mechanism |
|
| 15765409 |
| MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.70 | 17174718 17334410 11903743 21278145 11408273 17157831 16943688 16239168 16221502 |
| MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.08 | 15034207 9327722 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.38 | 18418968 16248980 17525996 12632514 12667390 12389079 15876570 18054572 12546737 17708605 13678700 18210741 18156304 12445418 10355542 17714472 12898905 16015684 18412020 15338365 16027843 15673190 17557913 17922224 17640975 18251166 18205269 16638106 18395914 18376398 18279442 17823541 12445421 12666154 17721639 15370692 15818738 14512876 11481614 15730626 14724832 17805973 18420326 17761835 16011737 14716496 15052691 14620537 16033810 18006644 20821823 15925388 12958196 17698563 17869086 14716833 18317297 18705752 18481824 16136751 17900296 16097048 15362042 15931870 17481882 15959796 18429990 17766677 18472332 18277467 17631135 14748882 18166357 16192424 15650968 12632512 12609069 18472094 17976157 18395095 17944888 18263696 15123356 16116963 12649538 15893842 12586293 15057751 17565644 15996030 18339082 12741479 18187930 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
3.38 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.38 | 12878042 |
| MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
4.16 | 16964402 17285989 15720792 16246199 15830285 |
| MESH:D008107 |
Liver Diseases |
|
polyphenols |
4.16 | 16698588 |
| MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.97 | 15123358 |
| MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.52 | 16899240 14706259 |
| MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
4.16 | 19294768 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.16 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
9.10 | 598648 1399818 3712494 6587162 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
9.10 | 12014681 15583823 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.10 | 12151625 |
| MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.82 | 21114838 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.23 | 11884234 19555203 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ibuprofen |
3.59 | 10697514 |
| MESH:D020326 |
Migraine without Aura |
|
Cyclic AMP |
4.97 | 11304026 |
| MESH:D009128 |
Muscle Spasticity |
|
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
12.94 | 17220914 |
| MESH:D009128 |
Muscle Spasticity |
|
Win 55212-2 |
12.94 | 17220914 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.87 | 12213967 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.67 | 18551238 |
| MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.39 | 3581430 |
| MESH:D009395 |
Nephritis, Interstitial |
|
Ibuprofen |
4.79 | 6375363 |
| MESH:D009410 |
Nerve Degeneration |
|
Ibuprofen |
4.24 | 10961664 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.03 | 14600291 |
| MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.41 | 6679447 |
| MESH:D009436 |
Neural Tube Defects |
|
Tetrahydrocannabinol |
7.41 | 19040278 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.33 | 12819281 16049721 |
| MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.33 | 4026338 6482804 |
| MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.83 | 3988306 |
| MESH:D010003 |
Osteoarthritis |
|
Ibuprofen |
4.02 | 7009135 |
| MESH:D010024 |
Osteoporosis |
|
Calcium |
3.66 | 17882678 |
| MESH:D010146 |
Pain |
|
Ibuprofen |
3.78 | 3291741 |
| MESH:D010149 |
Pain, Postoperative |
|
Ibuprofen |
4.95 | 16678543 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Ibuprofen |
3.42 | 12384795 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.51 | 11578682 |
| MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.30 | 7296757 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.06 | 12520081 |
| MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.28 | 6228378 |
| MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.36 | 11605937 12224865 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.37 | 18163543 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.00 | 11399792 11118676 11896295 11222880 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Ibuprofen |
4.29 | 17409433 |
| MESH:D011507 |
Proteinuria |
|
Ibuprofen |
4.45 | 6375363 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.12 | 16919318 15861022 |
| MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.61 | 10835634 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.65 | 18990726 |
| MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.23 | 3692021 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.41 | 18551238 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.75 | 16709447 |
| MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.06 | 17997062 |
| MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.00 | 15821434 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.44 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.99 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.71 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.74 | 6582329 1399818 6587162 3712494 7505956 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
4.76 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.76 | 8074119 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.12 | 10091137 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.12 | 14692618 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.40 | 12125929 |
| MESH:D020301 |
Vasospasm, Intracranial |
|
Ibuprofen |
5.00 | 19057314 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.37 | 14671159 15869587 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.06 | 15886252 |